Summary

The global oral solid dosage manufacturing market is poised for substantial expansion over the coming years, driven by increasing pharmaceutical production, rising prevalence of chronic diseases, and growing demand for generic medications. The market, valued at USD 608.9 billion in 2026, is projected to reach USD 10,020.2 billion by 2033, registering a compound annual growth rate (CAGR) of 4.80% during the forecast period.



Market Insights



Oral solid dosage forms, including tablets, capsules, powders, and granules, remain the most widely used methods for delivering therapeutic compounds. Their ease of administration, patient compliance, stability, and cost-effectiveness make them a preferred choice in the pharmaceutical industry. The market is witnessing continuous innovation in formulation and manufacturing processes, enabling higher precision, enhanced bioavailability, and targeted delivery of medications.



Technological advancements in granulation, coating, and compression methods are further optimizing production efficiency. In addition, the rising focus on contract manufacturing has led to significant collaborations between pharmaceutical companies and specialized manufacturing organizations, enabling scalable production and reduced time-to-market for new drugs.



Drivers of Market Growth



Several factors are fueling growth in the oral solid dosage manufacturing market:



1. Rising Pharmaceutical Demand: The global increase in chronic conditions such as cardiovascular diseases, diabetes, and cancer has significantly boosted the demand for oral solid medications.



2. Generic Drug Expansion: Patent expirations on major drugs have accelerated generic drug production, driving the need for large-scale, high-quality manufacturing capabilities.



3. Technological Advancements: Innovations in tablet press machines, capsule filling equipment, and granulation systems enhance production efficiency, reduce waste, and maintain stringent quality standards.



4. Contract Manufacturing Trends: Pharmaceutical companies increasingly rely on contract manufacturing organizations (CMOs) to reduce operational costs, improve production capacity, and focus on core research and development activities.



5. Regulatory Compliance: Increasing adherence to global regulatory standards ensures high-quality production, which, in turn, fosters market growth and strengthens consumer trust.



Business Opportunities



The oral solid dosage manufacturing market presents ample opportunities for both established players and new entrants. Emerging markets, particularly in Asia Pacific and Latin America, are witnessing rising pharmaceutical consumption due to growing populations, improving healthcare infrastructure, and increasing awareness of chronic disease management.



Investments in advanced equipment, automation, and process optimization are enabling manufacturers to enhance productivity and minimize production costs. Additionally, the rising trend of personalized medicine and demand for specialty formulations creates avenues for niche product development and specialized contract manufacturing services.



Regional Analysis



North America dominates the market due to a strong pharmaceutical base, high healthcare expenditure, and advanced manufacturing infrastructure. The region is also home to several leading contract manufacturing organizations, providing a competitive edge to local and global pharmaceutical companies.



Europe follows closely, supported by stringent regulatory frameworks, strong generic drug production, and continuous investment in pharmaceutical R&D. Countries such as Germany, France, and the United Kingdom are key contributors to market growth in this region.



The Asia Pacific market is expanding rapidly due to increasing healthcare access, growing generic drug production, and cost-effective manufacturing facilities. India and China, in particular, are major hubs for both domestic and export-oriented oral solid dosage manufacturing.



Latin America and the Middle East & Africa are emerging markets with significant growth potential, driven by improving healthcare infrastructure, rising pharmaceutical demand, and government initiatives to enhance drug availability and affordability.



Key Players



The global oral solid dosage manufacturing market is highly competitive, with several key players operating across different regions:



• Alcami



• Piramal Pharma Solutions



• Cambrex



• Corden Pharma



• CMIC



• Almac



• Pfizer Inc.



• Contract Pharmacal



• Aenova



• Catalent



• Delpharm



• Madras Pharmaceuticals



• Micro Lab



• Hetero Drugs



• Patheon



• Recipharm



These players are investing in advanced manufacturing technologies, strategic collaborations, and capacity expansions to strengthen their market position and meet rising global demand.



Segmentation



The market is segmented based on dosage form, manufacturing technology, equipment type, service type, end user, and geography:



By Dosage Form



• Tablets



• Capsules



• Powders



• Granules



By Manufacturing Technology



• Wet Granulation



• Dry Granulation



• Direct Compression



• Coating & Specialized Processes



By Equipment Type



• Tablet Press Machines



• Capsule Filling Machines



• Granulation Equipment



• Coating Equipment



• Dryers & Mixers



By Service Type



• Contract Manufacturing



• In-house Manufacturing



By End User



• Pharmaceutical Companies



• Contract Manufacturing Organizations (CMOs)



• Biotechnology Companies



• Generic Drug Manufacturers



By Geography



• North America



• Europe



• Asia Pacific



• Latin America



• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Oral Solid Dosage Manufacturing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
3.1. Global Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
3.1.1. Tablets
3.1.2. Capsules
3.1.3. Powders
3.1.4. Granules
3.2. Global Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
3.2.1. Wet Granulation
3.2.2. Dry Granulation
3.2.3. Direct Compression
3.2.4. Coating & Specialized Processes
3.3. Global Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
3.3.1. Tablet Press Machines
3.3.2. Capsule Filling Machines
3.3.3. Granulation Equipment
3.3.4. Coating Equipment
3.3.5. Dryers & Mixers
3.4. Global Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
3.4.1. Contract Manufacturing
3.4.2. In-house Manufacturing
3.5. Global Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.5.1. Pharmaceutical Companies
3.5.2. Contract Manufacturing Organizations (CMOs)
3.5.3. Biotechnology Companies
3.5.4. Generic Drug Manufacturers
3.6. Global Oral Solid Dosage Manufacturing Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Latin America
3.6.5. Middle East & Africa
4. North America Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
4.1. North America Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
4.1.1. Tablets
4.1.2. Capsules
4.1.3. Powders
4.1.4. Granules
4.2. North America Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
4.2.1. Wet Granulation
4.2.2. Dry Granulation
4.2.3. Direct Compression
4.2.4. Coating & Specialized Processes
4.3. North America Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
4.3.1. Tablet Press Machines
4.3.2. Capsule Filling Machines
4.3.3. Granulation Equipment
4.3.4. Coating Equipment
4.3.5. Dryers & Mixers
4.4. North America Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
4.4.1. Contract Manufacturing
4.4.2. In-house Manufacturing
4.5. North America Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.5.1. Pharmaceutical Companies
4.5.2. Contract Manufacturing Organizations (CMOs)
4.5.3. Biotechnology Companies
4.5.4. Generic Drug Manufacturers
4.6. North America Oral Solid Dosage Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.6.1. U.S. Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
4.6.2. U.S. Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
4.6.3. U.S. Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
4.6.4. U.S. Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
4.6.5. U.S. Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
4.6.6. Canada Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
4.6.7. Canada Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
4.6.8. Canada Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
4.6.9. Canada Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
4.6.10. Canada Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
4.7. BPS Analysis/Market Attractiveness Analysis
5. Europe Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
5.1. Europe Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
5.1.1. Tablets
5.1.2. Capsules
5.1.3. Powders
5.1.4. Granules
5.2. Europe Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
5.2.1. Wet Granulation
5.2.2. Dry Granulation
5.2.3. Direct Compression
5.2.4. Coating & Specialized Processes
5.3. Europe Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
5.3.1. Tablet Press Machines
5.3.2. Capsule Filling Machines
5.3.3. Granulation Equipment
5.3.4. Coating Equipment
5.3.5. Dryers & Mixers
5.4. Europe Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
5.4.1. Contract Manufacturing
5.4.2. In-house Manufacturing
5.5. Europe Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.5.1. Pharmaceutical Companies
5.5.2. Contract Manufacturing Organizations (CMOs)
5.5.3. Biotechnology Companies
5.5.4. Generic Drug Manufacturers
5.6. Europe Oral Solid Dosage Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.6.1. Germany Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.2. Germany Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.3. Germany Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.4. Germany Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.5. Germany Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.6. Italy Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.7. Italy Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.8. Italy Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.9. Italy Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.10. Italy Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.11. France Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.12. France Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.13. France Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.14. France Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.15. France Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.16. U.K. Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.17. U.K. Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.18. U.K. Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.19. U.K. Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.20. U.K. Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.21. Spain Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.22. Spain Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.23. Spain Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.24. Spain Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.25. Spain Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.26. Russia Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.27. Russia Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.28. Russia Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.29. Russia Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.30. Russia Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.6.31. Rest of Europe Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
5.6.32. Rest of Europe Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
5.6.33. Rest of Europe Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
5.6.34. Rest of Europe Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
5.6.35. Rest of Europe Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
5.7. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
6.1. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
6.1.1. Tablets
6.1.2. Capsules
6.1.3. Powders
6.1.4. Granules
6.2. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
6.2.1. Wet Granulation
6.2.2. Dry Granulation
6.2.3. Direct Compression
6.2.4. Coating & Specialized Processes
6.3. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
6.3.1. Tablet Press Machines
6.3.2. Capsule Filling Machines
6.3.3. Granulation Equipment
6.3.4. Coating Equipment
6.3.5. Dryers & Mixers
6.4. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
6.4.1. Contract Manufacturing
6.4.2. In-house Manufacturing
6.5. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.5.1. Pharmaceutical Companies
6.5.2. Contract Manufacturing Organizations (CMOs)
6.5.3. Biotechnology Companies
6.5.4. Generic Drug Manufacturers
6.6. Asia Pacific Oral Solid Dosage Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.6.1. China Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.2. China Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.3. China Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.4. China Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.5. China Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.6.6. Japan Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.7. Japan Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.8. Japan Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.9. Japan Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.10. Japan Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.6.11. South Korea Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.12. South Korea Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.13. South Korea Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.14. South Korea Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.15. South Korea Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.6.16. India Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.17. India Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.18. India Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.19. India Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.20. India Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.6.21. Southeast Asia Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.22. Southeast Asia Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.23. Southeast Asia Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.24. Southeast Asia Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.25. Southeast Asia Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.6.26. Rest of SAO Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
6.6.27. Rest of SAO Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
6.6.28. Rest of SAO Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
6.6.29. Rest of SAO Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
6.6.30. Rest of SAO Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
6.7. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
7.1. Latin America Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
7.1.1. Tablets
7.1.2. Capsules
7.1.3. Powders
7.1.4. Granules
7.2. Latin America Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
7.2.1. Wet Granulation
7.2.2. Dry Granulation
7.2.3. Direct Compression
7.2.4. Coating & Specialized Processes
7.3. Latin America Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
7.3.1. Tablet Press Machines
7.3.2. Capsule Filling Machines
7.3.3. Granulation Equipment
7.3.4. Coating Equipment
7.3.5. Dryers & Mixers
7.4. Latin America Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
7.4.1. Contract Manufacturing
7.4.2. In-house Manufacturing
7.5. Latin America Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.5.1. Pharmaceutical Companies
7.5.2. Contract Manufacturing Organizations (CMOs)
7.5.3. Biotechnology Companies
7.5.4. Generic Drug Manufacturers
7.6. Latin America Oral Solid Dosage Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.6.1. Brazil Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
7.6.2. Brazil Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
7.6.3. Brazil Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
7.6.4. Brazil Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
7.6.5. Brazil Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
7.6.6. Mexico Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
7.6.7. Mexico Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
7.6.8. Mexico Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
7.6.9. Mexico Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
7.6.10. Mexico Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
7.6.11. Argentina Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
7.6.12. Argentina Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
7.6.13. Argentina Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
7.6.14. Argentina Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
7.6.15. Argentina Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
7.6.16. Rest of LATAM Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
7.6.17. Rest of LATAM Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
7.6.18. Rest of LATAM Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
7.6.19. Rest of LATAM Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
7.6.20. Rest of LATAM Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
7.7. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, 2020-2033
8.1. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
8.1.1. Tablets
8.1.2. Capsules
8.1.3. Powders
8.1.4. Granules
8.2. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, Value (US$ Bn), 2020-2033
8.2.1. Wet Granulation
8.2.2. Dry Granulation
8.2.3. Direct Compression
8.2.4. Coating & Specialized Processes
8.3. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, Value (US$ Bn), 2020-2033
8.3.1. Tablet Press Machines
8.3.2. Capsule Filling Machines
8.3.3. Granulation Equipment
8.3.4. Coating Equipment
8.3.5. Dryers & Mixers
8.4. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
8.4.1. Contract Manufacturing
8.4.2. In-house Manufacturing
8.5. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.5.1. Pharmaceutical Companies
8.5.2. Contract Manufacturing Organizations (CMOs)
8.5.3. Biotechnology Companies
8.5.4. Generic Drug Manufacturers
8.6. Middle East & Africa Oral Solid Dosage Manufacturing Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.6.1. GCC Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
8.6.2. GCC Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
8.6.3. GCC Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
8.6.4. GCC Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
8.6.5. GCC Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
8.6.6. South Africa Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
8.6.7. South Africa Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
8.6.8. South Africa Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
8.6.9. South Africa Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
8.6.10. South Africa Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
8.6.11. Egypt Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
8.6.12. Egypt Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
8.6.13. Egypt Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
8.6.14. Egypt Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
8.6.15. Egypt Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
8.6.16. Nigeria Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
8.6.17. Nigeria Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
8.6.18. Nigeria Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
8.6.19. Nigeria Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
8.6.20. Nigeria Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
8.6.21. Rest of Middle East Oral Solid Dosage Manufacturing Market Outlook, by Dosage Form, 2020-2033
8.6.22. Rest of Middle East Oral Solid Dosage Manufacturing Market Outlook, by Manufacturing Technology, 2020-2033
8.6.23. Rest of Middle East Oral Solid Dosage Manufacturing Market Outlook, by Equipment Type, 2020-2033
8.6.24. Rest of Middle East Oral Solid Dosage Manufacturing Market Outlook, by Service Type, 2020-2033
8.6.25. Rest of Middle East Oral Solid Dosage Manufacturing Market Outlook, by End User, 2020-2033
8.7. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Alcami
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Piramal Pharma Solutions
9.4.3. Cambrex
9.4.4. Corden Pharma
9.4.5. CMIC
9.4.6. Almac
9.4.7. Pfizer Inc.
9.4.8. Contract Pharmacal
9.4.9. Aenova
9.4.10. Catalent
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations